• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创造力、创新和精益西格玛:有争议的组合?

Creativity, innovation and lean sigma: a controversial combination?

机构信息

CVGI Research Area, Mereside, AstraZeneca R&D Alderley Park, Alderley Edge, SK10 4TG, UK.

出版信息

Drug Discov Today. 2011 Jan;16(1-2):50-7. doi: 10.1016/j.drudis.2010.11.005. Epub 2010 Nov 20.

DOI:10.1016/j.drudis.2010.11.005
PMID:21094693
Abstract

The application of lean sigma is gaining momentum in drug discovery and development but it remains controversial because of perceptions that process improvement will suppress much-needed creativity and innovation. We review the conditions required to support creativity and innovation and the principles and benefits of lean sigma in a drug discovery environment. We conclude that it is desirable to create a unified climate that encourages and enables both innovation and continuous improvement and that this is possible if three key tensions are handled carefully and with due respect to the needs of research. These three potential traps occur in the interpretation of standardization, the role of variation and the choice of how to use liberated capacity.

摘要

精益西格玛在药物发现和开发中的应用正在兴起,但由于人们认为流程改进会抑制急需的创造力和创新,因此仍存在争议。我们回顾了支持创造力和创新所需的条件,以及精益西格玛在药物发现环境中的原则和益处。我们的结论是,理想情况下,应该营造一种鼓励和支持创新和持续改进的统一氛围,如果能够谨慎处理并充分考虑研究需求,这是可能的。这三个潜在的陷阱出现在对标准化的解释、变化的作用以及如何利用解放的能力的选择上。

相似文献

1
Creativity, innovation and lean sigma: a controversial combination?创造力、创新和精益西格玛:有争议的组合?
Drug Discov Today. 2011 Jan;16(1-2):50-7. doi: 10.1016/j.drudis.2010.11.005. Epub 2010 Nov 20.
2
Helping science to succeed: improving processes in R&D.助力科学取得成功:改进研发流程。
Drug Discov Today. 2008 Mar;13(5-6):227-33. doi: 10.1016/j.drudis.2007.11.011. Epub 2008 Mar 5.
3
Deploying continuous improvement across the drug discovery value chain.在药物发现价值链中部署持续改进。
Drug Discov Today. 2011 Jun;16(11-12):467-71. doi: 10.1016/j.drudis.2011.03.007. Epub 2011 Apr 3.
4
A case study of lean drug discovery: from project driven research to innovation studios and process factories.精益药物研发案例研究:从项目驱动型研究到创新工作室与流程工厂
Drug Discov Today. 2008 Jun;13(11-12):543-50. doi: 10.1016/j.drudis.2008.03.011. Epub 2008 Apr 28.
5
Innovation in health care: a primer.医疗保健领域的创新:入门指南。
Am J Med Qual. 2008 Sep-Oct;23(5):382-8. doi: 10.1177/1062860608317695.
6
Making continuous quality improvement a reality: innovation skills.
J Healthc Mater Manage. 1991 Oct;9(9):68-70.
7
Creating, improving, and innovating.创造、改进和创新。
Qual Manag Health Care. 1994 Spring;2(3):56-61.
8
What is the most important approach in current drug discovery: doing the right things or doing things right?在当前的药物发现中,最重要的方法是什么:做正确的事还是把事情做对?
Drug Discov Today. 2012 Nov;17(21-22):1166-9. doi: 10.1016/j.drudis.2012.04.009. Epub 2012 Apr 27.
9
The road ahead for large pharma: long-term science and innovation.大型制药公司的未来之路:长期的科学与创新。
Drug Discov Today. 2009 May;14(9-10):439-41. doi: 10.1016/j.drudis.2009.03.002. Epub 2009 Mar 9.
10
Organizing for innovation: towards successful translational research.为创新而组织:迈向成功的转化研究。
Trends Biotechnol. 2009 Oct;27(10):558-61. doi: 10.1016/j.tibtech.2009.06.007. Epub 2009 Aug 14.

引用本文的文献

1
Tools, techniques, organisation and culture of the CADD group at Sygnature Discovery.西格奈特发现公司计算机辅助药物设计团队的工具、技术、组织和文化。
J Comput Aided Mol Des. 2017 Mar;31(3):305-308. doi: 10.1007/s10822-016-9989-x. Epub 2016 Oct 31.
2
Evaluation of sampling spacing in pharmacokinetic studies using six sigma method.采用六西格玛法评估药代动力学研究中的采样间距。
J Pharmacokinet Pharmacodyn. 2014 Jun;41(3):251-60. doi: 10.1007/s10928-014-9361-5. Epub 2014 Jun 22.
3
Simulating the drug discovery pipeline: a Monte Carlo approach.
模拟药物发现管道:一种蒙特卡罗方法。
J Cheminform. 2012 Nov 27;4(1):32. doi: 10.1186/1758-2946-4-32.
4
Integrating experimentation and quantitative modeling to enhance discovery of Beta amyloid lowering therapeutics for Alzheimer's disease.整合实验和定量建模以增强阿尔茨海默病β淀粉样蛋白降低治疗药物的发现。
Front Pharmacol. 2012 Oct 4;3:177. doi: 10.3389/fphar.2012.00177. eCollection 2012.
5
The influence of the 'organizational factor' on compound quality in drug discovery.“组织因素”对药物发现中化合物质量的影响。
Nat Rev Drug Discov. 2011 Sep 30;10(10):749-65. doi: 10.1038/nrd3552.